The Effects of an Individualized Smartphone-Based Exercise Program on Self-defined Motor Tasks in Parkinson Disease: Pilot Interventional Study.
Parkinson disease
exercise
mobile phone
patient-defined outcome measure
telemedicine
wearable sensors
Journal
JMIR rehabilitation and assistive technologies
ISSN: 2369-2529
Titre abrégé: JMIR Rehabil Assist Technol
Pays: Canada
ID NLM: 101703412
Informations de publication
Date de publication:
15 Nov 2022
15 Nov 2022
Historique:
received:
26
04
2022
accepted:
07
09
2022
revised:
10
08
2022
entrez:
15
11
2022
pubmed:
16
11
2022
medline:
16
11
2022
Statut:
epublish
Résumé
Bradykinesia and rigidity are prototypical motor impairments of Parkinson disease (PD) highly influencing everyday life. Exercise training is an effective treatment alternative for motor symptoms, complementing dopaminergic medication. High frequency training is necessary to yield clinically relevant improvements. Exercise programs need to be tailored to individual symptoms and integrated in patients' everyday life. Due to the COVID-19 pandemic, exercise groups in outpatient setting were largely reduced. Developing remotely supervised solutions is therefore of significant importance. This pilot study aimed to evaluate the feasibility of a digital, home-based, high-frequency exercise program for patients with PD. In this pilot interventional study, patients diagnosed with PD received 4 weeks of personalized exercise at home using a smartphone app, remotely supervised by specialized therapists. Exercises were chosen based on the patient-defined motor impairment and depending on the patients' individual capacity (therapists defined 3-5 short training sequences for each participant). In a first education session, the tailored exercise program was explained and demonstrated to each participant and they were thoroughly introduced to the smartphone app. Intervention effects were evaluated using the Unified Parkinson Disease Rating Scale, part III; standardized sensor-based gait analysis; Timed Up and Go Test; 2-minute walk test; quality of life assessed by the Parkinson Disease Questionnaire; and patient-defined motor tasks of daily living. Usability of the smartphone app was assessed by the System Usability Scale. All participants gave written informed consent before initiation of the study. In total, 15 individuals with PD completed the intervention phase without any withdrawals or dropouts. The System Usability Scale reached an average score of 72.2 (SD 6.5) indicating good usability of the smartphone app. Patient-defined motor tasks of daily living significantly improved by 40% on average in 87% (13/15) of the patients. There was no significant impact on the quality of life as assessed by the Parkinson Disease Questionnaire (but the subsections regarding mobility and social support improved by 14% from 25 to 21 and 19% from 15 to 13, respectively). Motor symptoms rated by Unified Parkinson Disease Rating Scale, part III, did not improve significantly but a descriptive improvement of 14% from 18 to 16 could be observed. Clinically relevant changes in Timed Up and Go test, 2-minute walk test, and sensor-based gait parameters or functional gait tests were not observed. This pilot interventional study presented that a tailored, digital, home-based, and high-frequency exercise program over 4 weeks was feasible and improved patient-defined motor activities of daily life based on a self-developed patient-defined impairment score indicating that digital exercise concepts may have the potential to beneficially impact motor symptoms of daily living. Future studies should investigate sustainability effects in controlled study designs conducted over a longer period.
Sections du résumé
BACKGROUND
BACKGROUND
Bradykinesia and rigidity are prototypical motor impairments of Parkinson disease (PD) highly influencing everyday life. Exercise training is an effective treatment alternative for motor symptoms, complementing dopaminergic medication. High frequency training is necessary to yield clinically relevant improvements. Exercise programs need to be tailored to individual symptoms and integrated in patients' everyday life. Due to the COVID-19 pandemic, exercise groups in outpatient setting were largely reduced. Developing remotely supervised solutions is therefore of significant importance.
OBJECTIVE
OBJECTIVE
This pilot study aimed to evaluate the feasibility of a digital, home-based, high-frequency exercise program for patients with PD.
METHODS
METHODS
In this pilot interventional study, patients diagnosed with PD received 4 weeks of personalized exercise at home using a smartphone app, remotely supervised by specialized therapists. Exercises were chosen based on the patient-defined motor impairment and depending on the patients' individual capacity (therapists defined 3-5 short training sequences for each participant). In a first education session, the tailored exercise program was explained and demonstrated to each participant and they were thoroughly introduced to the smartphone app. Intervention effects were evaluated using the Unified Parkinson Disease Rating Scale, part III; standardized sensor-based gait analysis; Timed Up and Go Test; 2-minute walk test; quality of life assessed by the Parkinson Disease Questionnaire; and patient-defined motor tasks of daily living. Usability of the smartphone app was assessed by the System Usability Scale. All participants gave written informed consent before initiation of the study.
RESULTS
RESULTS
In total, 15 individuals with PD completed the intervention phase without any withdrawals or dropouts. The System Usability Scale reached an average score of 72.2 (SD 6.5) indicating good usability of the smartphone app. Patient-defined motor tasks of daily living significantly improved by 40% on average in 87% (13/15) of the patients. There was no significant impact on the quality of life as assessed by the Parkinson Disease Questionnaire (but the subsections regarding mobility and social support improved by 14% from 25 to 21 and 19% from 15 to 13, respectively). Motor symptoms rated by Unified Parkinson Disease Rating Scale, part III, did not improve significantly but a descriptive improvement of 14% from 18 to 16 could be observed. Clinically relevant changes in Timed Up and Go test, 2-minute walk test, and sensor-based gait parameters or functional gait tests were not observed.
CONCLUSIONS
CONCLUSIONS
This pilot interventional study presented that a tailored, digital, home-based, and high-frequency exercise program over 4 weeks was feasible and improved patient-defined motor activities of daily life based on a self-developed patient-defined impairment score indicating that digital exercise concepts may have the potential to beneficially impact motor symptoms of daily living. Future studies should investigate sustainability effects in controlled study designs conducted over a longer period.
Identifiants
pubmed: 36378510
pii: v9i4e38994
doi: 10.2196/38994
pmc: PMC9709672
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e38994Informations de copyright
©Heiko Gaßner, Jana Friedrich, Alisa Masuch, Jelena Jukic, Sabine Stallforth, Martin Regensburger, Franz Marxreiter, Jürgen Winkler, Jochen Klucken. Originally published in JMIR Rehabilitation and Assistive Technology (https://rehab.jmir.org), 15.11.2022.
Références
Mov Disord. 2016 Sep;31(9):1293-313
pubmed: 27452964
J Physiother. 2017 Apr;63(2):94-100
pubmed: 28342682
J Neurol Phys Ther. 2015 Oct;39(4):204-12
pubmed: 26308937
Mov Disord. 2006 Aug;21(8):1200-7
pubmed: 16673410
J Neurol. 2020 Jun;267(6):1594-1601
pubmed: 32048014
Ann Phys Rehabil Med. 2020 Nov;63(6):554-556
pubmed: 32315802
Clin Rehabil. 2018 Mar;32(3):299-311
pubmed: 28745063
IEEE J Biomed Health Inform. 2015 Nov;19(6):1873-81
pubmed: 26241979
Age Ageing. 1997 Sep;26(5):353-7
pubmed: 9351479
Front Neurol. 2019 Jan 22;10:5
pubmed: 30723450
JMIR Mhealth Uhealth. 2021 Jun 8;9(6):e16304
pubmed: 34100767
Lancet Neurol. 2014 Jun;13(6):557-66
pubmed: 24726066
Gait Posture. 2018 Jan;59:1-6
pubmed: 28963889
J Neural Transm (Vienna). 2015 Feb;122(2):253-6
pubmed: 24872078
Lancet Neurol. 2019 Jul;18(7):697-708
pubmed: 30975519
Neurodegener Dis Manag. 2017 Feb;7(1):73-84
pubmed: 28097926
BMJ. 2013 Jan 28;346:f167
pubmed: 23358487
Sensors (Basel). 2015 Mar 17;15(3):6419-40
pubmed: 25789489
Mov Disord. 2007 Jan;22(1):41-7
pubmed: 17115387
IEEE Trans Biomed Eng. 2015 Apr;62(4):1089-97
pubmed: 25389237
Medicina (Kaunas). 2020 Jul 17;56(7):
pubmed: 32708938
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
pubmed: 1564476
JMIR Res Protoc. 2016 Aug 26;5(3):e172
pubmed: 27565186
Eur J Phys Rehabil Med. 2020 Jun;56(3):331-334
pubmed: 32406226
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
PLoS One. 2013;8(2):e56956
pubmed: 23431395
Acad Med. 2017 Feb;92(2):157-160
pubmed: 27119325
J Eval Clin Pract. 2020 Apr;26(2):524-540
pubmed: 31840346
J Physiother. 2019 Oct;65(4):189-199
pubmed: 31521554
Front Neurol. 2017 Oct 26;8:550
pubmed: 29123499
Clin Rehabil. 2012 Sep;26(9):817-26
pubmed: 22257506
Clin Rehabil. 2005 Dec;19(8):870-7
pubmed: 16323386
J Neurol Neurosurg Psychiatry. 2000 Sep;69(3):308-12
pubmed: 10945804
BMJ. 2015 Feb 10;350:g7818
pubmed: 25670183
Phys Ther. 2012 Nov;92(11):1395-410
pubmed: 22822237
Gait Posture. 2017 Jun;55:138-144
pubmed: 28445854
Lancet Neurol. 2019 Nov;18(11):998-1008
pubmed: 31521532
JAMA Neurol. 2018 Jul 1;75(7):876-880
pubmed: 29582075
NPJ Parkinsons Dis. 2021 Mar 8;7(1):25
pubmed: 33686074
Nat Rev Neurol. 2017 Nov;13(11):689-703
pubmed: 29027544
Neurorehabil Neural Repair. 2017 Mar;31(3):217-227
pubmed: 27885161
Sensors (Basel). 2017 Jun 28;17(7):
pubmed: 28657587
J Parkinsons Dis. 2018;8(s1):S95-S100
pubmed: 30584167
J Neurol. 2020 Dec;267(12):3462-3464
pubmed: 32638108
J Parkinsons Dis. 2021;11(s1):S5-S10
pubmed: 33682728
J Parkinsons Dis. 2020;10(3):893-897
pubmed: 32538870